{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:00:15Z","timestamp":1790611215763,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-025-00582-2","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:07:59Z","timestamp":1758794879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrative structural profiling and ligand optimisation across the transthyretin mutational landscape"],"prefix":"10.1038","volume":"11","author":[{"given":"Ugo","family":"Lomoio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Carbonari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Manuel","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ortuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Li\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangelo","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Hiram","family":"Guzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"582_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/13506129.2012.668501","volume":"19","author":"MD Benson","year":"2012","unstructured":"Benson, M. D. Pathogenesis of transthyretin amyloidosis. Amyloid 19, 14\u201315 (2012).","journal-title":"Amyloid"},{"key":"582_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40120-020-00217-0","volume":"9","author":"MA Liz","year":"2020","unstructured":"Liz, M. A. et al. A narrative review of the role of transthyretin in health and disease. Neurol. Ther. 9, 395\u2013402 (2020).","journal-title":"Neurol. Ther."},{"key":"582_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/annotation\/2ea264c2-d70c-4a2e-b877-c084dc3a49db","volume":"8","author":"JA Ferreira","year":"2013","unstructured":"Ferreira, J. A. et al. Correction: structure-based analysis of a19d, a variant of transthyretin involved in familial amyloid cardiomyopathy. Plos One 8, 10\u20131371 (2013).","journal-title":"Plos One"},{"key":"582_CR4","doi-asserted-by":"publisher","first-page":"8672","DOI":"10.3390\/ijms21228672","volume":"21","author":"F Saponaro","year":"2020","unstructured":"Saponaro, F. et al. Transthyretin stabilization: an emerging strategy for the treatment of alzheimer\u2019s disease? Int. J. Mol. Sci. 21, 8672 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"582_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.febslet.2008.02.034","volume":"582","author":"J Costa","year":"2008","unstructured":"Costa, J. et al. Transthyretin binding to a-beta peptide - impact on a-beta fibrillogenesis and toxicity. FEBS Lett. 582, 936\u2013942 (2008).","journal-title":"FEBS Lett."},{"key":"582_CR6","doi-asserted-by":"publisher","first-page":"e48042","DOI":"10.1371\/journal.pone.0048042","volume":"7","author":"W Maetzler","year":"2012","unstructured":"Maetzler, W. et al. Serum and cerebrospinal fluid levels of transthyretin in lewy body disorders with and without dementia. Plos One 7, e48042 (2012).","journal-title":"Plos One"},{"key":"582_CR7","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1523\/JNEUROSCI.6012-08.2009","volume":"29","author":"TH Fleming","year":"2009","unstructured":"Fleming, T. H. et al. Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J. Neurosci. 29, 3220\u20133232 (2009).","journal-title":"J. Neurosci."},{"key":"582_CR8","doi-asserted-by":"publisher","first-page":"bbac230","DOI":"10.1093\/bib\/bbac230","volume":"23","author":"P Hiram Guzzi","year":"2022","unstructured":"Hiram Guzzi, P., Petrizzelli, F. & Mazza, T. Disease spreading modeling and analysis: a survey. Brief. Bioinforma. 23, bbac230 (2022).","journal-title":"Brief. Bioinforma."},{"key":"582_CR9","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1073\/pnas.0400062101","volume":"101","author":"N Reixach","year":"2004","unstructured":"Reixach, N. et al. Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Natl Acad. Sci. 101, 2817\u20132822 (2004).","journal-title":"Proc. Natl Acad. Sci."},{"key":"582_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08609-z","volume":"10","author":"AJ Yee","year":"2019","unstructured":"Yee, A. J. et al. A molecular mechanism for transthyretin amyloidogenesis. Nat. Commun. 10, 925 (2019).","journal-title":"Nat. Commun."},{"key":"582_CR11","doi-asserted-by":"publisher","first-page":"e202300164","DOI":"10.1002\/ijch.202300164","volume":"64","author":"P Hammarstr\u00f6m","year":"2024","unstructured":"Hammarstr\u00f6m, P. The transthyretin protein and amyloidosis\u2013an extraordinary chemical biology platform. Isr. J. Chem. 64, e202300164 (2024).","journal-title":"Isr. J. Chem."},{"key":"582_CR12","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/humu.23634","volume":"39","author":"MA Iacocca","year":"2018","unstructured":"Iacocca, M. A. et al. Clinvar database of global familial hypercholesterolemia-associated dna variants. Hum. Mutat. 39, 1631\u20131640 (2018).","journal-title":"Hum. Mutat."},{"key":"582_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson, P. D. et al. Human gene mutation database (HGMD\u00ae): 2003 update. Hum. Mutat. 21, 577\u2013581 (2003).","journal-title":"Hum. Mutat."},{"key":"582_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408363.2024.2350379","volume":"61","author":"ZL Almeida","year":"2024","unstructured":"Almeida, Z. L., Vaz, D. C. & Brito, R. M. Transthyretin mutagenesis: impact on amyloidogenesis and disease. Crit. Rev. Clin. Lab. Sci. 61, 1\u201325 (2024).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"582_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/13506129609014359","volume":"3","author":"LC Serpell","year":"1996","unstructured":"Serpell, L. C., Goldsteins, G., Dacklin, I., Lundgren, E. & Blake, C. C. The \u201cedge strand\u201d hypothesis: prediction and test of a mutational \u201chot-spot\u201d on the transthyretin molecule associated with fap amyloidogenesis. Amyloid 3, 75\u201385 (1996).","journal-title":"Amyloid"},{"key":"582_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamacardio.2020.5979","volume":"6","author":"A Shah","year":"2021","unstructured":"Shah, A. Misfolded transthyretin as a novel risk factor for heart failure. JAMA Cardiol. 6, 255\u2013257 (2021).","journal-title":"JAMA Cardiol."},{"key":"582_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","volume":"86","author":"Y Sekijima","year":"2015","unstructured":"Sekijima, Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J. Neurol. Neurosurg. Psychiatry 86, 1036\u20131043 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"582_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10072-020-04889-2","volume":"43","author":"F Manganelli","year":"2020","unstructured":"Manganelli, F. et al. Hereditary transthyretin amyloidosis overview. Neurological Sci. 43, 595\u2013604 (2020).","journal-title":"Neurological Sci."},{"key":"582_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15403\/jgld-2474","volume":"29","author":"M Luigetti","year":"2020","unstructured":"Luigetti, M. et al. Gastrointestinal manifestations in hereditary transthyretin amyloidosis: a single-centre experience. J. Gastrointest. Liver Dis. 29, 339\u2013343 (2020).","journal-title":"J. Gastrointest. Liver Dis."},{"key":"582_CR20","doi-asserted-by":"crossref","unstructured":"Mohan, C. et al. Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in india: an indian expert consensus. Indian Heart J. 74, 441\u2013449 (2022).","DOI":"10.1016\/j.ihj.2022.11.006"},{"key":"582_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03547-0","volume":"20","author":"D Delgado","year":"2025","unstructured":"Delgado, D. et al. Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review. Orphanet J. Rare Dis. 20, 29 (2025).","journal-title":"Orphanet J. Rare Dis."},{"key":"582_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","volume":"71","author":"L Rubin","year":"2020","unstructured":"Rubin, L. et al. Cardiac amyloidosis: overlooked, underappreciated, and treatable. Annu. Rev. Med. 71, 203\u2013219 (2020).","journal-title":"Annu. Rev. Med."},{"key":"582_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamacardio.2024.4102","volume":"10","author":"C Christoffersen","year":"2024","unstructured":"Christoffersen, C. et al. Transthyretin tetramer destabilization and increased mortality in the general population. JAMA Cardiol. 10, 155\u2013163 (2024).","journal-title":"JAMA Cardiol."},{"key":"582_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1080\/07853890.2021.1988696","volume":"53","author":"A Skrahina","year":"2021","unstructured":"Skrahina, A. et al. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology. Ann. Med. 53, 1787\u20131796 (2021).","journal-title":"Ann. Med."},{"key":"582_CR25","doi-asserted-by":"publisher","first-page":"944413","DOI":"10.3389\/fneur.2022.944413","volume":"13","author":"Y He","year":"2022","unstructured":"He, Y. et al. Association between serum transthyretin and intracranial atherosclerosis in patients with acute ischemic stroke. Front. Neurol. 13, 944413 (2022).","journal-title":"Front. Neurol."},{"key":"582_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07017-x","volume":"7","author":"Z Tong","year":"2017","unstructured":"Tong, Z. et al. Aggregated transthyretin is specifically packaged into placental nano-vesicles in preeclampsia. Sci. Rep. 7, 6694 (2017).","journal-title":"Sci. Rep."},{"key":"582_CR27","doi-asserted-by":"crossref","unstructured":"Kalkunte, S. et al. Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model. Am. J. Pathol. 183, 1425\u20131436 (2013).","DOI":"10.1016\/j.ajpath.2013.07.022"},{"key":"582_CR28","doi-asserted-by":"publisher","first-page":"3429541","DOI":"10.1155\/2020\/3429541","volume":"2020","author":"S Monu","year":"2020","unstructured":"Monu, S. et al. Plasma proteome profiling of coronary artery disease patients: downregulation of transthyretin-an important event. Mediators Inflamm. 2020, 3429541 (2020).","journal-title":"Mediators Inflamm."},{"key":"582_CR29","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15252\/emmm.201505357","volume":"7","author":"J Marcoux","year":"2015","unstructured":"Marcoux, J. et al. A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis. EMBO Mol. Med. 7, 1337\u20131349 (2015).","journal-title":"EMBO Mol. Med."},{"key":"582_CR30","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg, F. L. & Berk, J. L. Transthyretin (TTR) cardiac amyloidosis. Circulation 126, 1286\u20131300 (2012).","journal-title":"Circulation"},{"key":"582_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/jamacardio.2020.5969","volume":"6","author":"AM Greve","year":"2021","unstructured":"Greve, A. M. et al. Association of low plasma transthyretin concentration with risk of heart failure in the general population. JAMA Cardiol. 6, 258\u2013266 (2021).","journal-title":"JAMA Cardiol."},{"key":"582_CR32","doi-asserted-by":"publisher","first-page":"e33817","DOI":"10.1097\/MD.0000000000033817","volume":"102","author":"K Nichols","year":"2023","unstructured":"Nichols, K. et al. 1-hour versus 3-hour 99mTc-PYP imaging to evaluate suspected cardiac transthyretin amyloidosis. Medicine 102, e33817 (2023).","journal-title":"Medicine"},{"key":"582_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mus.26741","volume":"61","author":"H Koike","year":"2019","unstructured":"Koike, H. & Katsuno, M. Expanding the spectrum of transthyretin amyloidosis. Muscle Nerve 61, 3\u20134 (2019).","journal-title":"Muscle Nerve"},{"key":"582_CR34","doi-asserted-by":"crossref","unstructured":"Zitnik, M. Ai-enabled drug discovery reaches clinical milestone: machine learning. Nat. Med. 31, 2490\u20132491 (2025).","DOI":"10.1038\/s41591-025-03832-2"},{"key":"582_CR35","doi-asserted-by":"crossref","unstructured":"Giadone, A. et al. A library of attr amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics. Amyloid 25, 148\u2013155 (2018).","DOI":"10.1080\/13506129.2018.1489228"},{"key":"582_CR36","unstructured":"Nativi-Nicolau, J. et al. Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis outcomes survey. JACC Cardiooncol. 3, 537\u2013546 (2021)."},{"key":"582_CR37","doi-asserted-by":"crossref","unstructured":"Luigetti, M. et al. Serum inflammatory profile in hereditary transthyretin amyloidosis: mechanisms and possible therapeutic implications. Brain Sci. 12, 1708 (2022).","DOI":"10.3390\/brainsci12121708"},{"key":"582_CR38","doi-asserted-by":"crossref","unstructured":"Carroll, J. et al. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. J. Neurol. Neurosurg. Psychiatry 93, 668\u2013678 (2022).","DOI":"10.1136\/jnnp-2021-327909"},{"key":"582_CR39","unstructured":"M\u00fcllner, D. Modern hierarchical, agglomerative clustering algorithms. Preprint at https:\/\/arxiv.org\/abs\/1109.2378 (2011)."},{"key":"582_CR40","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","volume":"379","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 379, 1123\u20131130 (2023).","journal-title":"Science"},{"key":"582_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.21105\/joss.00861","volume":"3","author":"L McInnes","year":"2018","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).","journal-title":"J. Open Source Softw."},{"key":"582_CR42","doi-asserted-by":"publisher","first-page":"E2403","DOI":"10.1002\/humu.22619","volume":"35","author":"DM Rowczenio","year":"2014","unstructured":"Rowczenio, D. M. et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum. Mutat. 35, E2403\u2013E2412 (2014).","journal-title":"Hum. Mutat."},{"key":"582_CR43","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1006\/bbrc.2000.2554","volume":"270","author":"M Almeida","year":"2000","unstructured":"Almeida, M., Alves, I., Terazaki, H., Ando, Y. & Saraiva, M. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H AND TTR T119M. Biochem. Biophys. Res. Commun. 270, 1024\u20131028 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"582_CR44","doi-asserted-by":"crossref","unstructured":"do Amaral Martins, L. et al. Structural and thermodynamic characterization of a highly amyloidogenic dimer of transthyretin involved in a severe cardiomyopathy. J. Biol. Chem. 300, 107495 (2024).","DOI":"10.1016\/j.jbc.2024.107495"},{"key":"582_CR45","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.3233\/JND-150091","volume":"2","author":"A Mazzeo","year":"2015","unstructured":"Mazzeo, A. et al. Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in sicily, an italian endemic area. J. Neuromuscul. Dis. 2, S39\u2013S48 (2015).","journal-title":"J. Neuromuscul. Dis."},{"key":"582_CR46","doi-asserted-by":"publisher","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with alphamissense. Science 381, eadg7492 (2023).","journal-title":"Science"},{"key":"582_CR47","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1093\/bioinformatics\/btac678","volume":"38","author":"M Manfredi","year":"2022","unstructured":"Manfredi, M., Savojardo, C., Martelli, P. L. & Casadio, R. E-SNPs&GO: embedding of protein sequence and function improves the annotation of human pathogenic variants. Bioinformatics 38, 5168\u20135174 (2022).","journal-title":"Bioinformatics"},{"key":"582_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41588-023-01465-0","volume":"55","author":"N Brandes","year":"2023","unstructured":"Brandes, N., Goldman, G., Wang, C., Ye, C. & Ntranos, V. Genome-wide prediction of disease variant effects with a deep protein language model. Nat. Genet. 55, 1\u201311 (2023).","journal-title":"Nat. Genet."},{"key":"582_CR49","unstructured":"Zitnik, M. et al. Current and future directions in network biology. Bioinform Adv. 4, vbae099 (2024)."},{"key":"582_CR50","unstructured":"Corso, G., St\u00e4rk, H., Jing, B., Barzilay, R. & Jaakkola, T. Diffdock: Diffusion steps, twists, and turns for molecular docking. In International Conference on Learning Representations (ICLR) (ICLR, 2023)."},{"key":"582_CR51","unstructured":"Corso, G., Deng, A., Polizzi, N., Barzilay, R. & Jaakkola, T. Deep confident steps to new pockets: Strategies for docking generalization. In International Conference on Learning Representations (ICLR) (ICLR, 2024)."},{"key":"582_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"582_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40120-016-0040-x","volume":"5","author":"T Coelho","year":"2016","unstructured":"Coelho, T. et al. Mechanism of action and clinical application of tafamidis in hereditary transthyretin amyloidosis. Neurol. Ther. 5, 1\u201325 (2016).","journal-title":"Neurol. Ther."},{"key":"582_CR54","unstructured":"FDA. FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis, https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatments-heart-disease-caused-serious-rare-disease-transthyretin-mediated (2019)."},{"key":"582_CR55","unstructured":"FDA. FDA approves drug for heart disorder caused by transthyretin-mediated amyloidosis, https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-drug-heart-disorder-caused-transthyretin-mediated-amyloidosis (2024)."},{"key":"582_CR56","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa2305434","volume":"390","author":"JD Gillmore","year":"2024","unstructured":"Gillmore, J. D. et al. Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy. N. Engl. J. Med. 390, 132\u2013142 (2024).","journal-title":"N. Engl. J. Med."},{"key":"582_CR57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s43588-024-00737-x","volume":"4","author":"A Schneuing","year":"2024","unstructured":"Schneuing, A. et al. Structure-based drug design with equivariant diffusion models. Nat. Comput. Sci. 4, 899\u2013909 (2024).","journal-title":"Nat. Comput. Sci."},{"key":"582_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/bip.22130","volume":"99","author":"L Tolentino-Lopez","year":"2013","unstructured":"Tolentino-Lopez, L. et al. Outside-binding site mutations modify the active site\u2019s shapes in neuraminidase from influenza a h1n1. Biopolymers 99, 10\u201321 (2013).","journal-title":"Biopolymers"},{"key":"582_CR59","doi-asserted-by":"publisher","first-page":"e6290","DOI":"10.1371\/journal.pone.0006290","volume":"4","author":"S Palaninathan","year":"2009","unstructured":"Palaninathan, S. et al. Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and x-ray structural analysis. PloS One 4, e6290 (2009).","journal-title":"PloS One"},{"key":"582_CR60","first-page":"100721","volume":"21","author":"KF Morris","year":"2020","unstructured":"Morris, K. F., Geoghegan, R. M., Palmer, E. E., George, M. & Fang, Y. Molecular dynamics simulation study of ag10 and tafamidis binding to the val122ile transthyretin variant. Biochem. Biophys. Rep. 21, 100721 (2020).","journal-title":"Biochem. Biophys. Rep."},{"key":"582_CR61","doi-asserted-by":"crossref","unstructured":"Desai, D. et al. Review of AlphaFold 3: transformative advances in drug design and therapeutics. Cureus 16, e63646 (2024).","DOI":"10.7759\/cureus.63646"},{"key":"582_CR62","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/nar\/gki524","volume":"33","author":"Y Zhang","year":"2005","unstructured":"Zhang, Y. & Skolnick, J. Tm-align: a protein structure alignment algorithm based on the tm-score. Nucleic Acids Res. 33, 2302\u20132309 (2005).","journal-title":"Nucleic Acids Res."},{"key":"582_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-024-03327-8","volume":"11","author":"H Tordai","year":"2024","unstructured":"Tordai, H. et al. Analysis of alphamissense data in different protein groups and structural context. Sci. Data 11, 495 (2024).","journal-title":"Sci. Data"},{"key":"582_CR64","unstructured":"ntranoslab. VESM: co-distillation of esm models for variant effect prediction, https:\/\/huggingface.co\/spaces\/ntranoslab\/vesm-variants (2025)."},{"key":"582_CR65","doi-asserted-by":"publisher","first-page":"e2016239118","DOI":"10.1073\/pnas.2016239118","volume":"118","author":"A Rives","year":"2021","unstructured":"Rives, A. et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proc. Natl Acad. Sci. 118, e2016239118 (2021).","journal-title":"Proc. Natl Acad. Sci."},{"key":"582_CR66","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.1109\/TPAMI.2021.3095381","volume":"44","author":"A Elnaggar","year":"2022","unstructured":"Elnaggar, A. et al. Prottrans: toward understanding the language of life through self-supervised learning. IEEE Trans. Pattern Anal. Mach. Intell. 44, 7112\u20137127 (2022).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"582_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/bioinformatics\/btt691","volume":"30","author":"DE Pires","year":"2014","unstructured":"Pires, D. E., Ascher, D. B. & Blundell, T. L. MCSM: predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics 30, 335\u2013342 (2014).","journal-title":"Bioinformatics"},{"key":"582_CR68","doi-asserted-by":"publisher","first-page":"W229","DOI":"10.1093\/nar\/gkx439","volume":"45","author":"AP Pandurangan","year":"2017","unstructured":"Pandurangan, A. P., Ochoa-Montano, B., Ascher, D. B. & Blundell, T. L. SDM: a server for predicting effects of mutations on protein stability. Nucleic acids Res. 45, W229\u2013W235 (2017).","journal-title":"Nucleic acids Res."},{"key":"582_CR69","doi-asserted-by":"publisher","first-page":"W314","DOI":"10.1093\/nar\/gku411","volume":"42","author":"DE Pires","year":"2014","unstructured":"Pires, D. E., Ascher, D. B. & Blundell, T. L. DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res. 42, W314\u2013W319 (2014).","journal-title":"Nucleic Acids Res."},{"key":"582_CR70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/pro.3942","volume":"30","author":"CH Rodrigues","year":"2021","unstructured":"Rodrigues, C. H., Pires, D. E. & Ascher, D. B. DynaMut2: assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci. 30, 60\u201369 (2021).","journal-title":"Protein Sci."},{"key":"582_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-019-2923-1","volume":"20","author":"L Montanucci","year":"2019","unstructured":"Montanucci, L., Capriotti, E., Frank, Y., Ben-Tal, N. & Fariselli, P. DDGun: an untrained method for the prediction of protein stability changes upon single and multiple point variations. BMC Bioinforma. 20, 1\u201310 (2019).","journal-title":"BMC Bioinforma."},{"key":"582_CR72","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/ijms22020606","volume":"22","author":"G Li","year":"2021","unstructured":"Li, G., Panday, S. K. & Alexov, E. SAAFEC-SEQ: a sequence-based method for predicting the effect of single point mutations on protein thermodynamic stability. Int. J. Mol. Sci. 22, 606 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"582_CR73","doi-asserted-by":"publisher","unstructured":"Guzzi, P. H. & Roy, S. Biological network analysis: trends, approaches, graph theory, and algorithms. Academic Press https:\/\/doi.org\/10.1016\/C2018-0-01461-9 (2020).","DOI":"10.1016\/C2018-0-01461-9"},{"key":"582_CR74","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1021\/cr3002356","volume":"113","author":"L Di Paola","year":"2013","unstructured":"Di Paola, L., De Ruvo, M., Paci, P., Santoni, D. & Giuliani, A. Protein contact networks: an emerging paradigm in chemistry. Chem. Rev. 113, 1598\u20131613 (2013).","journal-title":"Chem. Rev."},{"key":"582_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30052-w","volume":"13","author":"PH Guzzi","year":"2023","unstructured":"Guzzi, P. H. et al. Computational analysis of the sequence-structure relation in sars-cov-2 spike protein using protein contact networks. Sci. Rep. 13, 2837 (2023).","journal-title":"Sci. Rep."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00582-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:03:03Z","timestamp":1758798183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00582-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00582-2","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}